HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the

UNSUBSCRIBE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease

WWW.INVOKANA.COM

Moved Permanently. The document has moved here.

INVOKANA.COM

Moved Permanently. The document has moved here.

TERMS OF SERVICE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease

PRIVACY POLICY

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR example from vomiting, diarrhea, or being in the sun too long. • Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people

UNSUBSCRIBE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease

WWW.INVOKANA.COM

Moved Permanently. The document has moved here.

INVOKANA.COM

Moved Permanently. The document has moved here.

TERMS OF SERVICE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR example from vomiting, diarrhea, or being in the sun too long. • Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people

UNSUBSCRIBE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease

TERMS OF SERVICE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT Eligible commercial patients pay $0 per month for INVOKANA®, INVOKAMET® XR, and INVOKAMET®, subject to monthly program benefit limits. There is no limit to this benefit for your first month of treatment, and then a $200 limit for each month thereafter. There is a $3,000 maximum program benefit per calendar year.

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at 1-800-526-7736. Please read full Product Information and Medication Guide for INVOKANA®. Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation.

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in DIABETIC KIDNEY DISEASE Diabetic kidney disease progresses slowly and silently—often showing no symptoms until later stages. In other words, your kidneys may not warn you that they’re in danger until things have advanced. People with DKD often don’t know they have it. In the meantime, damage could be building up over time, and the kidneys may eventually fail. THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease. to reduce the risk of end-stage kidney GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR example from vomiting, diarrhea, or being in the sun too long. • Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people

UNSUBSCRIBE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease

TERMS OF SERVICE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT If you use commercial or private health insurance to pay for your medication: Janssen CarePath Savings Program for INVOKANA ®, INVOKAMET ® XR, and INVOKAMET ®. Eligible commercial patients pay $0 per month for INVOKANA ®, INVOKAMET ® XR, and INVOKAMET ®, subject to monthly program benefit limits.There is no limit to this benefit for your first month of treatment, and then a $200 limit

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease DIABETIC KIDNEY DISEASE Our kidneys are superheroes in our bodies. They do so much for us! Every 30 minutes, they filter all of our blood to clear out waste and toxins, they help control blood pressure, they produce substances that keep our bodies healthy and regulated, and more.. In people with type 2 diabetes, there is increased pressure in the glomerulus (the filtering part of the kidneys).

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the HOMEPAGE | INVOKANA® (CANAGLIFLOZIN)ABOUT INVOKANADIABETIC KIDNEY DISEASETYPE 2 DIABETESSAVINGS AND SUPPORT INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease ABOUT INVOKAMET® & INVOKAMET® XR INVOKANA ® / INVOKAMET ® / INVOKAMET ® XR can cause serious side effects, including:. Lactic acidosis. Metformin, one of the medicines in INVOKAMET ® /INVOKAMET ® XR, can cause a rare but serious condition called lactic acidosis (a build-up of lactic acid in the blood) that can cause death. Lactic acidosis is a medical emergency and must be treated in the hospital. SAVINGS AND COST SUPPORT If you use commercial or private health insurance to pay for your medication: Janssen CarePath Savings Program for INVOKANA ®, INVOKAMET ® XR, and INVOKAMET ®. Eligible commercial patients pay $0 per month for INVOKANA ®, INVOKAMET ® XR, and INVOKAMET ®, subject to monthly program benefit limits.There is no limit to this benefit for your first month of treatment, and then a $200 limit

TYPE 2 DIABETES

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease CONTACT US | INVOKANA INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease DIABETIC KIDNEY DISEASE Our kidneys are superheroes in our bodies. They do so much for us! Every 30 minutes, they filter all of our blood to clear out waste and toxins, they help control blood pressure, they produce substances that keep our bodies healthy and regulated, and more.. In people with type 2 diabetes, there is increased pressure in the glomerulus (the filtering part of the kidneys).

INVOKANA® FAQS

Yes! INVOKANA ® was the first SGLT2 inhibitor to be approved for use in the United States—SGLT2 inhibitors are a class of type 2 diabetes medicines that work with the kidneys, along with diet and exercise, to help lower A1C. In addition to significantly lowering A1C, INVOKANA ® is the first type 2 diabetes pill approved to lower the risk of heart attack, stroke, and cardiovascular death in THANK YOU FOR REGISTERING INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR WHAT IS INVOKANA®? • INVOKANA® (canagliflozin) is a prescription medicine used: ° along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes

REBATE FORM

Rebate Form Get started Please read the full Prescribing Information, including Boxed Warning(s), for INVOKANA®, INVOKAMET®, and INVOKAMET® XR , and the GIVE YOUR KIDNEYS THE ATTENTION THEY DESERVE— TALK TO YOUR example from vomiting, diarrhea, or being in the sun too long. • Ketoacidosis (increased ketones in your blood or urine). Ketoacidosis has happened in people

UNSUBSCRIBE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known heart disease

TERMS OF SERVICE

INVOKANA ® (canagliflozin) is a prescription medicine used: . along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease Skip to main content Learn more about Janssen’s COVID-19 response and our continued support to help patients afford and access our medicines. Google Tag Manager * Product Information

* INVOKANA®

* INVOKAMET® XR

* INVOKAMET®

* Medication Guide

* INVOKANA®

* INVOKAMET® XR

* INVOKAMET®

* Important Safety Information * For Healthcare Professionals

* For US Patients

Toggle navigation

* About INVOKANA®

* What is INVOKANA®? * How INVOKANA® Works * What are INVOKAMET® XR and INVOKAMET®?

* FAQs

* Diabetic Kidney Disease

* Type 2 Diabetes

* Savings and Support * Product Information

* INVOKANA®

* INVOKAMET® XR

* INVOKAMET®

* Medication Guide

* INVOKANA®

* INVOKAMET® XR

* INVOKAMET®

* Important Safety Information * For Healthcare Professionals

* For US Patients

IF YOU HAVE TYPE 2 DIABETES—YOUR KIDNEYS NEED ATTENTION!

LEARN MORE

INVOKANA® IS THE FIRST TYPE 2 DIABETES MEDICATION PROVEN IN A LANDMARK CLINICAL STUDY TO LOWER THE RISK OF: * END-STAGE KIDNEY DISEASE (ESKD) * WORSENING OF KIDNEY FUNCTION * CARDIOVASCULAR DEATH * HOSPITALIZATION FOR HEART FAILURE In adults with type 2 diabetes and diabetic kidney disease (nephropathy) with a certain amount of protein in the urine.

INVOKANA® ALSO:

* LOWERS THE RISK of HEART ATTACK, STROKE, or CARDIOVASCULAR DEATH in people with type 2 diabetes and established cardiovascular disease. * LOWERS BLOOD SUGAR (A1C) in adults with type 2 diabetes, along with diet and exercise.

LEARN MORE

TYPE 2 DIABETES CAN REALLY HURT YOUR KIDNEYS—AND YOU MAY NOT EVEN KNOW IT’S HAPPENING. Our kidneys work hard to do some VERY important things for us. But unfortunately type 2 diabetes can cause DIABETIC KIDNEY DISEASE, a serious situation that can have NO EARLY SYMPTOMS and can lead to dialysis, transplant, hospitalization for heart failure, and even death. What should you do? What’s an EGFR NUMBER—and why is it important to know it? LEARN THE ANSWERS to these important questions

and more here.

GET THE FACTS

JANSSEN WANTS TO HELP YOU EXPLORE COST SUPPORT OPTIONS FOR

INVOKANA®.

We’d like to help! Learn if you’re eligible for savings options,

and get support.

EXPLORE SAVINGS OPTIONS

WHAT IS INVOKANA®?

* INVOKANA® (canagliflozin) is a prescription medicine used: * along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes * to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease * to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic kidney disease (nephropathy) with a certain amount of protein in the

urine

* INVOKANA® is not for people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in blood or

urine).

* INVOKANA® is not used to lower blood sugar (glucose) in adults with type 2 diabetes with severe kidney problems. * It is not known if INVOKANA® is safe and effective in children under 18 years of age. IMPORTANT SAFETY INFORMATION INVOKANA® CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING: * AMPUTATIONS. INVOKANA® MAY INCREASE YOUR RISK OF LOWER-LIMB AMPUTATIONS.  AMPUTATIONS MAINLY INVOLVE REMOVAL OF THE TOE OR PART OF THE FOOT; HOWEVER, AMPUTATIONS INVOLVING THE LEG, BELOW AND ABOVE THE KNEE, HAVE ALSO OCCURRED. SOME PEOPLE HAD MORE THAN ONE AMPUTATION, SOME ON BOTH SIDES OF THE BODY. You may be at a higher risk of lower-limb amputation if you: have a history of amputation, have heart disease or are at risk for heart disease, have had blocked or narrowed blood vessels (usually in leg), have damage to the nerves (neuropathy) in the leg, or have had diabetic foot ulcers or sores. CALL YOUR DOCTOR RIGHT AWAY IF YOU HAVE NEW PAIN OR TENDERNESS, ANY SORES, ULCERS, OR INFECTIONS IN YOUR LEG OR FOOT. Your doctor may decide to stop your INVOKANA® for a while if you have any of these signs or symptoms. Talk to your doctor about proper foot care. * DEHYDRATION.  INVOKANA® CAN CAUSE SOME PEOPLE TO BECOME DEHYDRATED (THE LOSS OF TOO MUCH BODY WATER), WHICH MAY CAUSE YOU TO FEEL DIZZY, FAINT, LIGHTHEADED, OR WEAK, ESPECIALLY WHEN YOU STAND UP (ORTHOSTATIC HYPOTENSION). THERE HAVE BEEN REPORTS OF SUDDEN WORSENING OF KIDNEY FUNCTION IN PEOPLE WITH TYPE 2 DIABETES WHO ARE TAKING INVOKANA®. You may be at higher risk of dehydration if you take medicines to lower your blood pressure (including diuretics ), are on a low sodium (salt) diet, have kidney problems, or are 65 years of age or older. Talk to your doctor about what you can do to prevent dehydration including how much fluid you should drink on a daily basis.  Call your healthcare provider right away if you reduce the amount of food or liquid you drink, for example if you cannot eat or you start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long. * KETOACIDOSIS (INCREASED KETONES IN YOUR BLOOD OR URINE). Ketoacidosis has happened in people who have TYPE 1 OR TYPE 2 DIABETES, during treatment with INVOKANA®. Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with INVOKANA®.  Ketoacidosis is a serious condition, which may need to be treated in a hospital. Ketoacidosis may lead to death. KETOACIDOSIS CAN HAPPEN WITH INVOKANA® EVEN IF YOUR BLOOD SUGAR IS LESS THAN 250 MG/DL. STOP TAKING INVOKANA® AND CALL YOUR DOCTOR RIGHT AWAY IF YOU GET ANY OF THE FOLLOWING SYMPTOMS: nausea, vomiting, stomach-area pain, tiredness, or trouble breathing. If you get any of these symptoms during treatment with INVOKANA®, if possible, check for ketones in your urine, even if your blood sugar is less than 250 mg/dL. * VAGINAL YEAST INFECTION. Symptoms of a vaginal yeast infection include: vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), or vaginal itching. * YEAST INFECTION OF THE SKIN AROUND THE PENIS (BALANITIS OR BALANOPOSTHITIS). Swelling of an uncircumcised penis may develop that makes it difficult to pull back the skin around the tip of the penis. Other symptoms include: redness, itching, or swelling of the penis; rash of the penis; foul-smelling discharge from the penis; or pain in the skin around penis. Talk to your doctor about what to do if you get symptoms of a yeast infection of the vagina or penis. DO NOT TAKE INVOKANA® IF YOU: * are allergic to canagliflozin or any of the ingredients in INVOKANA®. Symptoms of allergic reaction to INVOKANA® may include: rash; raised red patches on your skin (hives); swelling of the face, lips, mouth, tongue, and throat that may cause difficulty in breathing

or swallowing

* are on kidney dialysis BEFORE TAKING INVOKANA®, TELL YOUR DOCTOR IF YOU: have a history of amputation; have heart disease or are at risk for heart disease; have had blocked or narrowed blood vessels (usually in leg); have damage to the nerves (neuropathy) in your leg; have had diabetic foot ulcers or sores; have kidney problems; have liver problems; have a history of urinary tract infections or problems with urination; are on a low sodium (salt) diet; are going to have surgery (your doctor may stop your INVOKANA® before you have surgery; talk to your doctor if you are having surgery about when to stop taking INVOKANA® and when to start it again); are eating less or there is a change in diet; have or have had pancreas problems; drink alcohol very often (or drink a lot of alcohol in the short-term); or ever had an allergic reaction to

INVOKANA®.

TELL YOUR DOCTOR IF YOU ARE OR PLAN TO BECOME PREGNANT, ARE BREASTFEEDING, OR PLAN TO BREASTFEED. INVOKANA® may harm your unborn baby. If you become pregnant while taking INVOKANA®, tell your doctor right away. INVOKANA® may pass into your breast milk and may harm your baby. Do not breastfeed while taking INVOKANA®. TELL YOUR DOCTOR ABOUT ALL THE MEDICINES YOU TAKE, INCLUDING PRESCRIPTION AND NON-PRESCRIPTION MEDICINES, VITAMINS, AND HERBAL SUPPLEMENTS. Especially tell your doctor if you take diuretics (water pills), rifampin (used to treat or prevent tuberculosis), phenytoin or phenobarbital (used to control seizures), ritonavir (Norvir®, Kaletra®– used to treat HIV infection), or digoxin (Lanoxin®– used to treat heart problems). POSSIBLE SIDE EFFECTS OF INVOKANA® INVOKANA® MAY CAUSE SERIOUS SIDE EFFECTS, INCLUDING: * SERIOUS URINARY TRACT INFECTIONS: may lead to hospitalization and have happened in people taking INVOKANA®. Tell your doctor if you have any signs or symptoms of a urinary tract infection such as: burning feeling while urinating, need to urinate often or right away, pain in the lower part of your stomach (pelvis), or blood in the urine. Some people may also have fever, back pain, nausea, or

vomiting

* LOW BLOOD SUGAR (HYPOGLYCEMIA). If you take INVOKANA® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea medicine or insulin may need to be lowered while you take INVOKANA®. Signs and symptoms of low blood sugar may include: headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, shaking, or

feeling jittery

* A RARE BUT SERIOUS BACTERIAL INFECTION THAT CAUSES DAMAGE TO THE TISSUE UNDER THE SKIN (NECROTIZING FASCIITIS) IN THE AREA BETWEEN AND AROUND THE ANUS AND GENITALS (PERINEUM). Necrotizing fasciitis of the perineum has happened in people who take INVOKANA®. Necrotizing fasciitis of the perineum may lead to hospitalization, may require multiple surgeries, and may lead to death. SEEK MEDICAL ATTENTION IMMEDIATELY IF YOU HAVE FEVER OR YOU ARE FEELING VERY WEAK, TIRED, OR UNCOMFORTABLE (MALAISE) AND YOU DEVELOP ANY OF THE FOLLOWING SYMPTOMS IN THE AREA BETWEEN AND AROUND YOUR ANUS AND GENITALS: pain or tenderness, swelling, or redness of the skin (erythema) * SERIOUS ALLERGIC REACTION. If you have any symptoms of a serious allergic reaction, stop taking INVOKANA® and call your doctor right away or go to the nearest hospital emergency room * BROKEN BONES (FRACTURES): Bone fractures have been seen in patients taking INVOKANA®. Talk to your doctor about factors that may increase your risk of bone fracture The most common side effects of INVOKANA® include: vaginal yeast infections and yeast infections of the penis; changes in urination, including urgent need to urinate more often, in larger amounts, or at

night.

These are not all the possible side effects of INVOKANA®. Tell your doctor if you have any side effect that bothers you or that does not go away. CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at

1-800-526-7736.

PLEASE READ FULL PRODUCT INFORMATION

and

MEDICATION GUIDE

for INVOKANA®.

Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation. Trademarks are those of their respective owners.

CP-68573V4

©Â JANSSEN PHARMACEUTICALS, INC. 2020. ALL RIGHTS RESERVED. This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional. This information is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico. Third party trademarks used herein are trademarks of their respective

owners.

Legal Notice | Privacy Policy | Contact Us | Site Map Do not sell my personal information Last updated October 2020 Questions? Call 877-468-6526 , Monday–Friday, 8 AM–8 PM ET Questions? Call 877-468-6526 , Monday–Friday, 8 AM–8 PM ET YOU ARE LEAVING THE INVOKANA® WEBSITE You are being directed to a third-party website: This link is provided for your convenience. Please note that this third-party website is not controlled by INVOKANA® or subject to our

privacy policy.

Thank you for visiting our site. We hope your visit was informative

and enjoyable.

CANCEL GO TO LINK

Important Safety Information

WHAT IS INVOKANA®?

* INVOKANA® (canagliflozin) is a prescription medicine used: * along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes * to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes who have known cardiovascular disease * to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic kidney disease (nephropathy) with a certain amount of protein in the

urine

* INVOKANA® is not for people with type 1 diabetes. It may increase their risk of diabetic ketoacidosis (increased ketones in blood or

urine).

* INVOKANA® is not used to lower blood sugar (glucose) in adults with type 2 diabetes with severe kidney problems. * It is not known if INVOKANA® is safe and effective in children under 18 years of age. IMPORTANT SAFETY INFORMATION INVOKANA® CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING: * AMPUTATIONS. INVOKANA® MAY INCREASE YOUR RISK OF LOWER-LIMB AMPUTATIONS.  AMPUTATIONS MAINLY INVOLVE REMOVAL OF THE TOE OR PART OF THE FOOT; HOWEVER, AMPUTATIONS INVOLVING THE LEG, BELOW AND ABOVE THE KNEE, HAVE ALSO OCCURRED. SOME PEOPLE HAD MORE THAN ONE AMPUTATION, SOME ON BOTH SIDES OF THE BODY. You may be at a higher risk of lower-limb amputation if you: have a history of amputation, have heart disease or are at risk for heart disease, have had blocked or narrowed blood vessels (usually in leg), have damage to the nerves (neuropathy) in the leg, or have had diabetic foot ulcers or sores. CALL YOUR DOCTOR RIGHT AWAY IF YOU HAVE NEW PAIN OR TENDERNESS, ANY SORES, ULCERS, OR INFECTIONS IN YOUR LEG OR FOOT. Your doctor may decide to stop your INVOKANA® for a while if you have any of these signs or symptoms. Talk to your doctor about proper foot care. * DEHYDRATION.  INVOKANA® CAN CAUSE SOME PEOPLE TO BECOME DEHYDRATED (THE LOSS OF TOO MUCH BODY WATER), WHICH MAY CAUSE YOU TO FEEL DIZZY, FAINT, LIGHTHEADED, OR WEAK, ESPECIALLY WHEN YOU STAND UP (ORTHOSTATIC HYPOTENSION). THERE HAVE BEEN REPORTS OF SUDDEN WORSENING OF KIDNEY FUNCTION IN PEOPLE WITH TYPE 2 DIABETES WHO ARE TAKING INVOKANA®. You may be at higher risk of dehydration if you take medicines to lower your blood pressure (including diuretics ), are on a low sodium (salt) diet, have kidney problems, or are 65 years of age or older. Talk to your doctor about what you can do to prevent dehydration including how much fluid you should drink on a daily basis.  Call your healthcare provider right away if you reduce the amount of food or liquid you drink, for example if you cannot eat or you start to lose liquids from your body, for example from vomiting, diarrhea, or being in the sun too long. * KETOACIDOSIS (INCREASED KETONES IN YOUR BLOOD OR URINE). Ketoacidosis has happened in people who have TYPE 1 OR TYPE 2 DIABETES, during treatment with INVOKANA®. Ketoacidosis has also happened in people with diabetes who were sick or who had surgery during treatment with INVOKANA®.  Ketoacidosis is a serious condition, which may need to be treated in a hospital. Ketoacidosis may lead to death. KETOACIDOSIS CAN HAPPEN WITH INVOKANA® EVEN IF YOUR BLOOD SUGAR IS LESS THAN 250 MG/DL. STOP TAKING INVOKANA® AND CALL YOUR DOCTOR RIGHT AWAY IF YOU GET ANY OF THE FOLLOWING SYMPTOMS: nausea, vomiting, stomach-area pain, tiredness, or trouble breathing. If you get any of these symptoms during treatment with INVOKANA®, if possible, check for ketones in your urine, even if your blood sugar is less than 250 mg/dL. * VAGINAL YEAST INFECTION. Symptoms of a vaginal yeast infection include: vaginal odor, white or yellowish vaginal discharge (discharge may be lumpy or look like cottage cheese), or vaginal itching. * YEAST INFECTION OF THE SKIN AROUND THE PENIS (BALANITIS OR BALANOPOSTHITIS). Swelling of an uncircumcised penis may develop that makes it difficult to pull back the skin around the tip of the penis. Other symptoms include: redness, itching, or swelling of the penis; rash of the penis; foul-smelling discharge from the penis; or pain in the skin around penis. Talk to your doctor about what to do if you get symptoms of a yeast infection of the vagina or penis. DO NOT TAKE INVOKANA® IF YOU: * are allergic to canagliflozin or any of the ingredients in INVOKANA®. Symptoms of allergic reaction to INVOKANA® may include: rash; raised red patches on your skin (hives); swelling of the face, lips, mouth, tongue, and throat that may cause difficulty in breathing

or swallowing

* are on kidney dialysis BEFORE TAKING INVOKANA®, TELL YOUR DOCTOR IF YOU: have a history of amputation; have heart disease or are at risk for heart disease; have had blocked or narrowed blood vessels (usually in leg); have damage to the nerves (neuropathy) in your leg; have had diabetic foot ulcers or sores; have kidney problems; have liver problems; have a history of urinary tract infections or problems with urination; are on a low sodium (salt) diet; are going to have surgery (your doctor may stop your INVOKANA® before you have surgery; talk to your doctor if you are having surgery about when to stop taking INVOKANA® and when to start it again); are eating less or there is a change in diet; have or have had pancreas problems; drink alcohol very often (or drink a lot of alcohol in the short-term); or ever had an allergic reaction to

INVOKANA®.

TELL YOUR DOCTOR IF YOU ARE OR PLAN TO BECOME PREGNANT, ARE BREASTFEEDING, OR PLAN TO BREASTFEED. INVOKANA® may harm your unborn baby. If you become pregnant while taking INVOKANA®, tell your doctor right away. INVOKANA® may pass into your breast milk and may harm your baby. Do not breastfeed while taking INVOKANA®. TELL YOUR DOCTOR ABOUT ALL THE MEDICINES YOU TAKE, INCLUDING PRESCRIPTION AND NON-PRESCRIPTION MEDICINES, VITAMINS, AND HERBAL SUPPLEMENTS. Especially tell your doctor if you take diuretics (water pills), rifampin (used to treat or prevent tuberculosis), phenytoin or phenobarbital (used to control seizures), ritonavir (Norvir®, Kaletra®– used to treat HIV infection), or digoxin (Lanoxin®– used to treat heart problems). POSSIBLE SIDE EFFECTS OF INVOKANA® INVOKANA® MAY CAUSE SERIOUS SIDE EFFECTS, INCLUDING: * SERIOUS URINARY TRACT INFECTIONS: may lead to hospitalization and have happened in people taking INVOKANA®. Tell your doctor if you have any signs or symptoms of a urinary tract infection such as: burning feeling while urinating, need to urinate often or right away, pain in the lower part of your stomach (pelvis), or blood in the urine. Some people may also have fever, back pain, nausea, or

vomiting

* LOW BLOOD SUGAR (HYPOGLYCEMIA). If you take INVOKANA® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea medicine or insulin may need to be lowered while you take INVOKANA®. Signs and symptoms of low blood sugar may include: headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, shaking, or

feeling jittery

* A RARE BUT SERIOUS BACTERIAL INFECTION THAT CAUSES DAMAGE TO THE TISSUE UNDER THE SKIN (NECROTIZING FASCIITIS) IN THE AREA BETWEEN AND AROUND THE ANUS AND GENITALS (PERINEUM). Necrotizing fasciitis of the perineum has happened in people who take INVOKANA®. Necrotizing fasciitis of the perineum may lead to hospitalization, may require multiple surgeries, and may lead to death. SEEK MEDICAL ATTENTION IMMEDIATELY IF YOU HAVE FEVER OR YOU ARE FEELING VERY WEAK, TIRED, OR UNCOMFORTABLE (MALAISE) AND YOU DEVELOP ANY OF THE FOLLOWING SYMPTOMS IN THE AREA BETWEEN AND AROUND YOUR ANUS AND GENITALS: pain or tenderness, swelling, or redness of the skin (erythema) * SERIOUS ALLERGIC REACTION. If you have any symptoms of a serious allergic reaction, stop taking INVOKANA® and call your doctor right away or go to the nearest hospital emergency room * BROKEN BONES (FRACTURES): Bone fractures have been seen in patients taking INVOKANA®. Talk to your doctor about factors that may increase your risk of bone fracture The most common side effects of INVOKANA® include: vaginal yeast infections and yeast infections of the penis; changes in urination, including urgent need to urinate more often, in larger amounts, or at

night.

These are not all the possible side effects of INVOKANA®. Tell your doctor if you have any side effect that bothers you or that does not go away. CALL YOUR DOCTOR FOR MEDICAL ADVICE ABOUT SIDE EFFECTS. YOU MAY REPORT SIDE EFFECTS TO THE FDA AT 1-800-FDA-1088. You may also report side effects to Janssen Scientific Affairs, LLC at

1-800-526-7736.

PLEASE READ FULL PRODUCT INFORMATION

and

MEDICATION GUIDE

for INVOKANA®.

Canagliflozin is licensed from Mitsubishi Tanabe Pharma Corporation. Trademarks are those of their respective owners.

CP-68573V4